Literature DB >> 12454256

Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis.

Ronak Rajani, John Smyth, C Geoff Koffman, Ian Abbs, David J A Goldsmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12454256     DOI： 10.1093/ndt/17.12.2278

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  10 in total

Review 1.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

2.  No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis.

Authors:  Guido Garosi; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-12       Impact factor: 2.370

Review 3.  Peritoneal dialysis associated infections: An update on diagnosis and management.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-08-06

Review 4.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

5.  mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.

Authors:  Maria Messina; Claudia Ariaudo; Alberto Mella; Vincenzo Cantaluppi; Giuseppe P Segoloni; Luigi Biancone
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

6.  Post-transplantation encapsulating peritoneal sclerosis in a pediatric patient.

Authors:  Nicole da Silva; Sofia Rocha; Liliana Rocha; Sameiro Faria; Teresa Costa; Conceição Mota
Journal:  Pediatr Nephrol       Date:  2012-04-24       Impact factor: 3.714

7.  m-TOR inhibitors may be useful in the treatment of encapsulating peritoneal sclerosis (EPS).

Authors:  Giovanni Maria Frascà; Mario D'Arezzo; Anna Maria Ricciatti; Emilio Balestra; Domenica Taruscia; Valentina Nastasi; Gaia Goteri
Journal:  J Nephrol       Date:  2014-02-12       Impact factor: 3.902

Review 8.  Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease.

Authors:  Zia Moinuddin; Angela Summers; David Van Dellen; Titus Augustine; Sarah E Herrick
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

9.  A case of fulminant sclerosing peritonitis presented like acute culture-negative peritonitis and successfully treated with corticosteroid therapy.

Authors:  Ji Yun Jung; Jong Tae Cho
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

Review 10.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.